CAPDM Reports

A Path Forward: Collaborative Solutions to Strengthen Canada's Drug Supply

​As drug shortages continue to escalate both globally and within Canada, driven by a complex mix of economic pressures, regulatory barriers, and lean supply chain limitations, the Canadian Generic Pharmaceutical Association (CGPA) and the Canadian Association for Pharmacy Distribution Management (CAPDM) have collaboratively developed a comprehensive report, A Path Forward: Collaborative Solutions to Strengthen Canada's Drug Supply, aimed at finding sustainable solutions. 

This report provides a clear and actionable roadmap for addressing Canada’s growing drug shortage crisis, highlighting key collaborative solutions essential for ensuring the consistent availability of critical medications to meet the needs of patients nationwide. 

 

Pharmaceutical Distribution: The Value and Challenges of Supplying Medications to Canada's Healthcare System

Canada’s pharmaceutical supply chain faces growing challenges as the demand for medications continues to rise. The Canadian Association for Pharmacy Distribution Management (CAPDM) released a landmark report—based on analysis conducted by IQVIA Canada—that shines a spotlight on the essential, though largely invisible, role of pharmaceutical distributors in safeguarding Canadians’ access to medications.

The report, Pharmaceutical Distribution: The Value and Challenges of Supplying Medications to Canada’s Healthcare System, offers a behind-the-scenes look at the sector, highlighting the growing need to recognize pharmaceutical distribution as a strategic asset amid increasingly specialized, decentralized, and patient-centered healthcare.